A global healthcare value consultancy combining strategic thinking with a reputation for excellence in outcomes research, health economics, and market access.
The Adelphi Values PCO UK team had a great time reconnecting in person at a summer day out event in Cheshire! The social team did a fantastic job planning activities that enabled the team to let their hair down and have some fun.
#teamworkmakesthedreamwork#AdelphiValuesPCO
The COVID-19 pandemic led to global lockdown measures and uncertainty on effective ways to slow progression. Data analysts at Adelphi Values PROVE™ have explored factors impacting transmission/fatality rates - contact us for more info on our white paper https://t.co/lAr6k8BEf5
Adelphi Values Patient-Centered Outcomes are pleased to share details of a new open-access manuscript (available here: https://t.co/JhGJr8YCIq) describing the patient experience of RLBP1 RP, a rare autosomal recessive form of retinitis pigmentosa’ #ophthalmology#RP#RLBP1RP
A study from authors @AdelphiValues and @Novartis aimed to better understand the patient experience of RLBP1 retinitis pigmentosa, read the #openaccess article here: https://t.co/ipHCDhvZnm #ophthalmology
The #AdelphiValuesPROVE team is walking, running and cycling throughout May to cross the 3,303.34 miles (5,316.22 km) from our office in Cheshire to New York in memory of a colleague who sadly lost their battle to cancer, to raise money for Cancer Research UK. Wish us luck!
April is #IBSAwarenessMonth, a common disorder that affects 10-15% of the global population. We all work together to raise awareness of the condition and encourage continued research, and we've worked with our clients on a nunber of IBS research projects
https://t.co/cEa5dfR7tW
The Fruitful Office scheme contributes to the planting of fruit trees in Malawi. As we continue to work remotely, we're delighted that our usual weekly fruit baskets are instead being donated to front-line NHS workers. We’re proud to support our wonderful NHS!
#StayHomeStaySafe
The Adelphi Values Patient-Centered Outcomes team have a new open-access manuscript published in Value in Health! This manuscript reports on the symptoms and health-related quality of life impacts of nasal polyps. You can read more here: https://t.co/m0ElVI5fpI
Our #AdelphiValuesPROVE team is getting into the spirit for #SportRelief2020! Dressing up for the day in a range of sports clothes (including helmets, flippers and boxing gloves...), our team is proudly helping to raise money for this very worthy cause.
https://t.co/yQtwfRV8Zs
The PCO team have published a manuscript in the Journal of Patient-Reported Outcomes. Reporting on the development and content validation of a new daily diary and an impact measure, both intended for use in clinical studies for endometriosis. Read more https://t.co/osTULwZn4z
Today is International #EpilepsyDay. 65 million people around the world are living with the condition. We have varied experience in epilepsy, including Dravet syndrome and Lennox-Gastaut syndrome
https://t.co/eho6RFX8j1
https://t.co/KRPDeZWdE6
Kim Cox, Director and Principal Statistician in our Patient-Centered Outcomes team, has continued her work with the SISAQOL consortium. Find the article here https://t.co/Qr3sMjxmZt and visit the interactive webtool: https://t.co/tY2glKiY6s
The Adelphi Values Patient-Centered Outcomes team have a new open-access manuscript published in Advances in Therapy! This study characterises core signs, symptoms and health-related quality of life impacts of chronic hand eczema. You can read more here: https://t.co/yPD8KeOwYD
#AdelphiValuesPROVE enjoyed a great year in 2019 – our growing team continued to deliver high quality services throughout the year to both existing and new clients, while further increasing our range of capabilities. We look forward to working with you in 2020!
Our #AdelphiValuesPROVE team is presenting our last poster today - come to location U17 to see our poster on 'Understanding the pricing and reimbursement landscape of orphan drugs in emerging markets' #ISPOREurope
Our poster 'Evaluating the economic and humanistic burden of type 2 diabetes mellitus in emerging markets compared to established markets' is at location F22 - author discussion hour taking place now! #ISPOREurope
Are you at #ISPOREurope? We're currently presenting a poster on 'Understanding the humanistic burden and patient impact in non-alcoholic steatohepatitis (NASH)' - come to location J14
Come to location J17 at #ISPOREurope for the author discussion hour on our poster 'Targeted literature review of discrete-choice experiment methodology, as applied to therapies in TDM2'
Come to location H7 at #ISPOREurope this afternoon to see the next poster presentation from #AdelphiValuesPROVE – ‘Use of cost-effectiveness affordability curves in evaluating cancer drugs in England’. The author discussion hour is from 6pm-7pm.
Come to location E12 at #ISPOREurope to see our poster on 'Incorporating the patients’ perspective in economic evaluations of healthcare'. Author discussion hour taking place now!